🔗 Share this article

Texas Attorney General Paxton is filing a lawsuit against the manufacturers of Tylenol, claiming the corporations withheld safety concerns that the drug created to pediatric cognitive development.

This legal action follows thirty days after Former President Trump publicized an unproven link between taking Tylenol - also known as paracetamol - throughout gestation and autism in offspring.

The attorney general is taking legal action against Johnson & Johnson, which once produced the medication, the exclusive pain medication approved for pregnant women, and the current manufacturer, which now manufacturers it.

In a official comment, he claimed they "deceived the public by profiting off of discomfort and promoting medication regardless of the risks."

The manufacturer asserts there is no credible evidence linking acetaminophen to autism.

"These companies misled for generations, deliberately risking numerous people to increase profits," Paxton, a Republican, stated.

The company said in a statement that it was "deeply concerned by the spread of false claims on the safety of acetaminophen and the possible consequences that could have on the welfare of women and children in America."

On its official site, the company also mentioned it had "consistently assessed the relevant science and there is lacking reliable evidence that indicates a proven link between taking acetaminophen and autism spectrum disorder."

Associations representing medical professionals and health professionals share this view.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in acetaminophen - is among limited choices for pregnant women to address discomfort and elevated temperature, which can create significant medical dangers if not addressed.

"In more than two decades of studies on the utilization of paracetamol in gestation, not a single reputable study has successfully concluded that the usage of acetaminophen in any trimester of gestation leads to neurodevelopmental disorders in young ones," the organization commented.

This legal action mentions recent announcements from the Trump administration in asserting the medication is reportedly hazardous.

In recent weeks, Trump raised alarms from medical authorities when he told expectant mothers to "resist strongly" not to consume Tylenol when unwell.

The FDA then released a statement that physicians should consider limiting the use of Tylenol, while also stating that "a causal relationship" between the medication and autism in young ones has remains unverified.

Health Secretary RFK Jr, who supervises the Food and Drug Administration, had promised in spring to undertake "extensive scientific investigation" that would establish the source of autism spectrum disorder in a limited time.

But specialists cautioned that discovering a single cause of autism - believed by scientists to be the outcome of a complicated interplay of inherited and surrounding conditions - would prove challenging.

Autism is a type of permanent neurological difference and impairment that affects how persons perceive and interact with the world, and is diagnosed using doctors' observations.

In his legal document, the attorney general - a Trump ally who is seeking federal office - asserts Kenvue and J&J "willfully ignored and sought to suppress the evidence" around paracetamol and autism.

The lawsuit attempts to require the corporations "eliminate any marketing or advertising" that asserts acetaminophen is reliable for expectant mothers.

The court case mirrors the complaints of a group of parents of minors with autism and attention deficit hyperactivity disorder who took legal action against the producers of acetaminophen in 2022.

Judicial authorities rejected the legal action, stating research from the parents' expert witnesses was lacking definitive proof.